MedPage Today

Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Early emicizumab ...
The American Journal of Managed Care

Report Details Rare Case of Acquired Hemophilia A Secondary to Immune Checkpoint Inhibition

This rare immune-related adverse event has only been previously reported 4 times in the context of immune checkpoint inhibitor (ICI) treatment. Acquired hemophilia A (AHA) occurs when a patient ...
The American Journal of Managed Care

Rare Risk of Acquired Hemophilia A Seen Following COVID-19 Infection, Vaccination

A group of researchers detailed a case of acquired hemophilia A (AHA) following infection and again following vaccination, and provided additional insights through their systematic review of available ...
ascopubs.org

Recombinant human activated FVII as prophylaxis in surgical treatment of cancer patient with acquired hemophilia A.

Chronic myeloid leukemia incidence trends among Caucasians in the United States. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text ...
Pharmabiz

China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura

China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura: Paris Friday, December 12, 2025, 09:00 Hrs [IST] The National ...
Business Wire

Baxter Submits Application for FDA Approval of OBI-1 for Patients with Acquired Hemophilia A

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced that the company has submitted a biologics license application (BLA) to the U.S. Food and Drug Administration ...